Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Helyx Industries SpA's Revenue for the
six
months ended in Dec. 2025 was €1.51 Mil. Helyx Industries SpA's average Accounts Receivable for the
six
months ended in Dec. 2025 was €0.64 Mil.
Hence, Helyx Industries SpA's Receivables Turnover for the
six
months ended in Dec. 2025 was 2.36.
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Helyx Industries SpA Receivables Turnover Related Terms
Helyx Industries SpA Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Helyx Industries SpA's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MIL:HLX vs VRTX, REGN, RVMD: Receivables Turnover Comparison
For the Biotechnology subindustry, Helyx Industries SpA's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Helyx Industries SpA Receivables Turnover vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Helyx Industries SpA's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Helyx Industries SpA's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Helyx Industries SpA (MIL:HLX) has a Receivables Turnover of 2.36 as of Dec. 2025. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Helyx Industries SpA and its competitors. According to the industry distribution chart, Helyx Industries SpA ranks #541 out of 840 companies in the Biotechnology industry, placing it in the top 64.4%.
Is Helyx Industries SpA's Receivables Turnover too high?
Helyx Industries SpA's current Receivables Turnover is 2.36. The Biotechnology industry median Receivables Turnover is 5.28. Helyx Industries SpA's value of 2.36 is 55.3% below this industry median. Based on the distribution chart, Helyx Industries SpA ranks #541 out of 840 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Helyx Industries SpA has a GF Score™ of 63/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Helyx Industries SpA's Receivables Turnover compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Helyx Industries SpA ranks #541 out of 840 companies for Receivables Turnover. This places Helyx Industries SpA in the lower half of its industry. The industry median Receivables Turnover is 5.28. Helyx Industries SpA's value of 2.36 is 55.3% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Biotechnology company?
The median Receivables Turnover among Biotechnology companies is 5.28, based on 840 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Helyx Industries SpA's current Receivables Turnover of 2.36 is 55.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Helyx Industries SpA and its competitors. For the Biotechnology industry, the median Receivables Turnover is 5.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Helyx Industries SpA's current Receivables Turnover is 2.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Helyx Industries SpA stock overvalued right now?
Based on GuruFocus' analysis, Helyx Industries SpA (MIL:HLX) is currently considered Possible Value Trap. The stock's GF Value™ is €3.49, compared to a current price of €0.70 — trading 79.9% below its estimated fair value. The current Receivables Turnover is 2.36 and 55.3% below the Biotechnology industry median of 5.28. Helyx Industries SpA's overall GF Score™ is 63/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Helyx Industries SpA (MIL:HLX), the current Receivables Turnover is 2.36 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Helyx Industries SpA (MIL:HLX) Overvalued in 2026?
Based on GuruFocus' analysis, Helyx Industries SpA stock appears to be undervalued.
The current stock price of €0.70 is trading 79.9% below its estimated GF Value™ of €3.49.
GuruFocus considers Helyx Industries SpA to be Possible Value Trap.
Key valuation signals for MIL:HLX:
Receivables Turnover: 2.36
GF Value™: €3.49 vs. price of €0.70 (79.9% below fair value)
Industry Position: 55.3% below the Biotechnology median (#541 of 840)
No single metric tells the full story. See the MIL:HLX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Helyx Industries SpA is a healthcare biotech company focusing on genetics. It is engaged in developing medical diagnostics, theranostics, and therapeutics solutions.
63GF Score
Get the complete analysis for MIL:HLX
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MIL:HLX has been successfully added to your 
